10-K
Annual Report
AIM IMMUNOTECH INC.
AIM
NYSEAMER
CIK: 946644
File #: 001-27072
Balance Sheet
39 line items · 2 periods
XBRL
| Item | Dec 31, 2025 | Dec 31, 2024 |
|---|---|---|
ASSETS | ||
Current assets: | ||
Cash and Cash Equivalents | 2,985,000 | 1,701,000 |
Cash and Cash Equivalents | 62,000 | 2,276,000 |
Fair Value, Recurring | 62,000 | 2,276,000 |
Fair Value, Inputs, Level 1 - Fair Value, Recurring | 62,000 | 2,276,000 |
Accounts Receivable | 7,000 | — |
Other Non-Operating Current Assets | 241,000 | 199,000 |
Total current assets | 3,295,000 | 4,176,000 |
Property, Plant and Equipment | 71,000 | 108,000 |
Operating Lease Right-of-Use Asset | 378,000 | 618,000 |
Intangible Assets | 1,661,000 | 2,594,000 |
Patents | 1,599,000 | 2,495,000 |
Trademarks | 62,000 | 99,000 |
Other Non-Operating Non-Current Assets | 377,000 | 1,112,000 |
Total assets | 5,782,000 | 8,608,000 |
LIABILITIES AND STOCKHOLDERS’ DEFICIT | ||
Current liabilities: | ||
Accounts Payable | 1,630,000 | 6,383,000 |
Other Current Liabilities | 795,000 | 606,000 |
Operating Lease Liability, Current | 250,000 | 239,000 |
Short-Term Debt | 3,549,000 | 2,307,000 |
Total current liabilities | 6,224,000 | 9,535,000 |
Long-term liability: | ||
Operating Lease Liability, Non-Current | 170,000 | 395,000 |
Long-Term Debt | 927,000 | — |
Other Non-Operating Non-Current Liabilities | 8,244,000 | — |
Fair Value, Recurring | 8,244,000 | — |
Fair Value, Inputs, Level 3 - Fair Value, Recurring | 8,244,000 | — |
Total liabilities | 15,565,000 | 9,930,000 |
Stockholders’ deficit: | ||
Total Stockholders' Equity | 3,000 | 1,000 |
Total Stockholders' Equity | 431,000,000 | 425,505,000 |
Total Stockholders' Equity | (440,786,000) | (426,828,000) |
Total stockholders’ deficit | (9,783,000) | (1,322,000) |
Common Stock | 3,000 | 1,000 |
Additional Paid-in Capital | 431,000,000 | 425,505,000 |
Retained Earnings | (440,786,000) | (426,828,000) |
Total liabilities and stockholders’ deficit | 5,782,000 | 8,608,000 |